Molecular Epidemiology of Fonsecaea Species

To assess population diversities among 81 strains of fungi in the genus Fonsecaea that had been identified down to species level, we applied amplified fragment-length polymorphism (AFLP) technology and sequenced the internal transcribed spacer regions and the partial cell division cycle, β-tubulin,...

Full description

Bibliographic Details
Published in:	Emerging Infectious Diseases
Main Authors:	Mohammad Javad Najafzadeh, Jiufeng Sun, Vania A. Vicente, Corne H.W. Klaassen, Alexandro Bonifaz, A.H.G. Gerrits van den Ende, Steph B.J. Menken, G. Sybren de Hoog
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2011-03-01
Subjects:	Chromoblastomycosis Fonsecaea distribution amplified fragment-length polymorphism AFLP fungi
Online Access:	https://wwwnc.cdc.gov/eid/article/17/3/10-0555_article

Similar Items

Comparative Genomics of Sibling Species of Fonsecaea Associated with Human Chromoblastomycosis
by: Vania A. Vicente, et al.
Published: (2017-10-01)

Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle
by: Sadia Khan, et al.
Published: (2015-03-01)

Extraction and virulence analysis of melanin from Fonsecaea monophora
by: Huan HUANG, et al.
Published: (2023-06-01)

<i>Agrobacterium tumefaciens</i>-Mediated Transformation of <i>Fonsecaea monophora</i> and <i>Fonsecaea erecta</i> for Host-Environment Interaction Studies
by: Cristina Isabel Ferrer Villena, et al.
Published: (2020-11-01)

Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis
by: Vidal Mônica Scarpelli Martinelli, et al.
Published: (2003-01-01)

Etymologia: Fonsecaea pedrosoi
by: Dayane Moraes, et al.
Published: (2023-07-01)

Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis
by: Claudio Guedes Salgado, et al.
Published: (2004-02-01)

Experimental murine chromoblastomycosis obtained from Fonsecaea pedrosoi isolate cultured for a long periodt
by: AP Machado, et al.
Published: (2009-01-01)

Cromoblastomicose produzida por Fonsecaea pedrosoi no Estado do Maranhão. I - aspectos clínicos, epidemiológicos e evolutivos
by: Ana Carla C. Mello e Silva, et al.
Published: (1992-03-01)

Establishment of epidemiological cutoff values for Fonsecaea pedrosoi, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications
by: Dallas J. Smith, et al.
Published: (2025-05-01)

Does DHN-Melanin Always Protect Fungi against Antifungal Drugs? The <i>Fonsecaea</i>/Micafungin Paradigm
by: Rowena Alves Coelho, et al.
Published: (2022-05-01)

Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with Fonsecaea monophora based on single-cell sequencing
by: Chen Wenyi, et al.
Published: (2025-01-01)

A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine
by: Xu-Cheng Shen, et al.
Published: (2020-02-01)

Fonsecaea associated cerebral phaeohyphomycosis in a post-COVID-19 patient: A first case report
by: Simin Laiq, et al.
Published: (2022-01-01)

HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in Fonsecaea pedrosoi
by: Vanila F. Palmeira, et al.
Published: (2017-05-01)

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus <i>Fonsecaea</i> sp.
by: Jorge Augusto Leão Pereira, et al.
Published: (2022-08-01)

Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole
by: Nora Cardona-Castro, et al.
Published: (1996-12-01)

Chromoblastomycosis in an Endemic Area of Brazil: A Clinical-Epidemiological Analysis and a Worldwide Haplotype Network
by: Daniel Wagner C. L. Santos, et al.
Published: (2020-10-01)

Electric Heating Pad as an Adjuvant Treatment of Extensive Chromoblastomycosis in Immunocompetent Patient: A Case Report
by: Hidayah RMN, et al.
Published: (2025-03-01)

Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora in vitro
by: Xinyao Liu, et al.
Published: (2025-01-01)

Environmental Screening of <i>Fonsecaea</i> Agents of Chromoblastomycosis Using Rolling Circle Amplification
by: Morgana Ferreira Voidaleski, et al.
Published: (2020-11-01)

Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo
by: Jing Zhang, et al.

Effects of ALA-PDT on the murine footpad model of Fonsecaea monophora infection and its related mechanisms in vivo
by: Xuelin Wu, et al.
Published: (2025-02-01)

Secretion of five extracellular enzymes by strains of chromoblastomycosis agents Secreção de cinco enzimas extracelulares por amostras de agentes da cromoblastomicose
by: Thais Furtado de Souza, et al.
Published: (2008-10-01)

Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis
by: Leandro C. D. Breda, et al.
Published: (2020-12-01)

Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole
by: Rowena Alves Coelho, et al.
Published: (2023-07-01)

In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals
by: Catalina de BEDOUT, et al.
Published: (1997-05-01)

Chromoblastomycosis in Peru: a retrospective review of 13 cases
by: Mercedes Sanchez-Diaz, et al.
Published: (2025-08-01)

Chromomycose cutanée à Fonsecaea Pedrosoi: à propos d'un cas
by: Kenza Baline, et al.
Published: (2018-06-01)

Fonsecaea Pedrosoi: A Rare Etiology in Fungal Keratitis
by: Jyoti Sangwan, et al.
Published: (2013-10-01)

Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015
by: Abdullah MS Al-Hatmi, et al.
Published: (2016-01-01)

Melanized meristematic mutant of Fonsecaea monophora promotes macrophage apoptosis
by: Minying LI, et al.
Published: (2022-04-01)

Partial chemical characterization of antigenic preparations of chromoblastomycosis agents Caracterização química parcial de preparações antigênicas de agentes da cromoblastomicose
by: Tania Fraga BARROS, et al.
Published: (1999-11-01)

Unusual Pigmented Fungal Keratitis by Fonsecaea Copper Pennies
by: Prakash Chand Agarwal, et al.
Published: (2014-07-01)

Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
by: Sudesh Gourav, et al.
Published: (2024-06-01)

A rare case of cerebral phaeohyphomycosis caused by Fonsecaea species in a renal transplant patient
by: Hammad Ul Haq Qureshi, et al.
Published: (2024-03-01)

Fonsecaea pedrosoi cerebral phaeohyphomycosis ("chromoblastomycosis"): first human culture-proven case reported in Brazil
by: José Paulo S. Nóbrega, et al.
Published: (2003-08-01)

Antifungal Susceptibility and Biological Characteristics of Fonsecaea monophora Causing Cerebral Phaeohyphomycosis in Jinhua, China
by: Bi W, et al.
Published: (2023-11-01)

Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system
by: Lysianne Pinto, et al.
Published: (2018-06-01)

Role of Dectin-1 in immune response of macrophages induced by Fonsecaea monophora wild strain and melanin-deficient mutant strain
by: Jiaojiao Zhong, et al.
Published: (2024-01-01)